Does NMN Actually Work? An Honest Look at the Evidence

Nicotinamide mononucleotide (NMN) is sold as an anti-aging supplement on the strength of one undeniable fact: it raises NAD+. The harder, less-marketed question is whether raising NAD+ actually does anything you can feel or measure — more muscle, better metabolism, more energy, a longer healthspan. When you separate those two questions, the honest answer is uncomfortable for the supplement aisle: NMN reliably moves the biomarker, but the human trials have so far failed to show it moves the outcomes most buyers are paying for.

This isn't a takedown. NMN is well tolerated, the NAD+ rise is real and replicated, and a couple of small functional signals exist. But "it raises a blood marker" and "it works" are different claims, and the evidence supports the first far more than the second.

What's actually proven: NMN raises blood NAD+

Start with the settled part. Oral NMN raises circulating NAD+ in a dose-dependent way and is well tolerated in healthy middle-aged adults ¹. A pharmaceutical-grade formulation (MIB-626) confirmed the same thing under tighter conditions — it reliably increased circulating NAD+ and its metabolome, clean target engagement ². So the foundational mechanistic claim checks out. If your only question is "does swallowing NMN raise the NAD+ level in my blood?", the answer is a confident yes.

The problem is that almost nobody buys NMN to raise a number on a lab panel. They buy it for what that number is supposed to deliver downstream. And that's where the evidence thins out fast.

What isn't proven: muscle, strength, and physical function

The cleanest test of "does NMN work" is whether it improves the things NAD+ is theorized to protect with age — muscle mass, strength, and walking ability. A 2025 systematic review and meta-analysis pooled the randomized trials of NMN (and its cousin NR) in older adults and looked exactly there ³. The result was a near-uniform null: NMN showed no significant effect on skeletal muscle index, handgrip strength, gait speed, or the chair-stand test, and the narrative synthesis found no improvement in knee-extension strength, the short physical performance battery, or thigh muscle mass either ³.

That is the single most important sentence on this page. The best-quality aggregate of the human data found that NMN did not measurably improve muscle or physical function — despite reliably raising NAD+ in those same kinds of participants. This is the "blood NAD+ ≠ tissue function" gap in its starkest form: the biomarker goes up, the body doesn't visibly follow.

What isn't proven: metabolism

Metabolic benefit is the other big NMN promise — better blood sugar, better lipids, a metabolism "reset." A separate 2024 meta-analysis pooled eight RCTs (250–2000 mg/day, 342 mostly non-diabetic adults) and found no significant benefit of NMN on fasting glucose, fasting insulin, HbA1c, HOMA-IR, or lipid profile ⁴. The authors' conclusion was blunt: short-term NMN did not show positive impacts on glucose control or lipid profile ⁴. Two independent meta-analyses, two different outcome families, the same answer.

The contested exception, and the soft signals

There is one famous positive result. A placebo-controlled trial reported that NMN improved muscle insulin sensitivity in prediabetic women ⁵. It's real and worth knowing — but it comes with two heavy caveats. The effect was narrow (weight and most metabolic markers were unchanged), and the finding was publicly contested by other researchers who questioned its strength and interpretation ⁶. Notably, the later, larger meta-analysis of glucose outcomes did not find a population-level metabolic benefit ⁴, so this is best read as a contested, narrow signal rather than a settled effect.

Beyond that, the positives are soft. A double-blind trial in older adults found NMN raised NAD+ and was associated with maintained walking speed and improved self-reported sleep quality — modest and partly subjective effects ⁷. And a small study in amateur runners reported enhanced aerobic capacity, attributed to better oxygen utilization rather than to changes in peak performance ⁸. These are the kinds of results that are easy to over-sell: publishable, but small, niche, and not the dramatic anti-aging payoff the marketing implies.

So — does NMN "work"?

It depends entirely on what you mean. If "work" means "raise NAD+," yes, clearly and repeatedly. If "work" means "demonstrably build muscle, fix metabolism, or reverse aging in humans," the honest answer is: not proven, and in the two best meta-analyses, not shown. NMN sits in the awkward middle that a lot of longevity supplements occupy — a real, measurable biochemical effect that hasn't yet translated into the felt or clinical outcomes people are buying it for. (NMN isn't unique here; the same biomarker-without-function pattern shows up across the category, which is why we keep the energy claims for NAD+ carefully separated from the biochemistry.)

None of this makes NMN a scam. The NAD+ rise is genuine, the safety record in trials is reassuring, and absence of proof in short trials isn't proof of absence over years. But a clear-eyed buyer should treat NMN as a plausible, well-tolerated bet on a mechanism — not as a product with proven outcomes. That framing should shape how much you pay and what you expect.

Bottom line

NMN reliably raises blood NAD+ and is well tolerated, but the strongest human evidence — two independent meta-analyses — found no significant benefit for muscle, physical function, glucose, or lipids. The lone insulin-sensitivity trial is narrow and contested; the walking, sleep, and aerobic-capacity signals are small. Raising the biomarker is the proven part; improving outcomes is the unproven part. For how NMN stacks up against NR head-to-head, see NMN vs NR — what the human trials show; for when that biomarker rise actually happens versus when felt benefits are claimed, see how long NMN takes to work; for the broader category, our pillar guide to NAD+ therapy evidence puts every route and precursor in context. And if you decide a precursor is worth a try anyway, choose on purity and price using the best NMN supplements, rated by evidence — and know in advance the reasons people stop taking NMN. For the newest precursor being pitched as an alternative, see whether trigonelline clears the same evidence bar (it doesn't yet).